Skip to Main Content
HealthCast Season 2 Episode 1 23m listen

Ensuring Participant Diversity in COVID-19 Vaccine Trials

Modern technology has the power to overcome clinical trial participation challenges.

The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.

Related Content
Woman listening to podcast

Stay in the Know

Subscribe now to receive our newsletters